Fujita et al. [20] studied 12503 unselected CRC patients and concluded that BRCA1 (OR = 2.6, P = 0.034) and BRCA2 (OR = 1.9, P = 0.0041) mutations were significantly associated with CRC. Here, BRCA2 is linked to colorectal carcinoma.